{"name":"Rohit Aggarwal, MD","slug":"rohit-aggarwal-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Adrenocorticotropic Hormone Gel","genericName":"Adrenocorticotropic Hormone Gel","slug":"adrenocorticotropic-hormone-gel","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Adrenocorticotropic Hormone Gel","genericName":"Adrenocorticotropic Hormone Gel","slug":"adrenocorticotropic-hormone-gel","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOdWk2emJLYm1lUTZtWnZ4Qk1RZUVlTG4yTXVBNlAyQ2RxV3hvbXJzZGxKd3RkQktqVkNNX2QwYmpIVFNpUVRkaG9ZOHV0LVBtRUNUQXlRallrR2k3MklXRVBTOHlmeGRWT3ZFN081SE9Kb2Rkb1gtUTYxdDFXNGxRdUhLWUkxZ1RwWFpZbElQQXd4MmV1YW5Cc0Zic0ZDNWVOS3dBQWdZRmJwa1Fm?oc=5","date":"2025-05-21","type":"trial","source":"Healio","summary":"Recent myositis trials produce both ‘successes and failures’ - Healio","headline":"Recent myositis trials produce both ‘successes and failures’","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQTjJzR0RWcjZDb1k5ZEk3bGQxTHhvbVBYdDB0eEVJdEpuRlprd0xGbXFOTnVZbW1XbUdEMVNESUt0NDdxNHNLbThqd202SkF4ZmV0U3NmUGRjNGhJUmVDVzNPVjJDS1dDbFJqM2ZTcmw5eU85VzBzTjdkbTV0N3FsdFJ3Z3lMZUEzM2E5cG9vN3hvNjI5LTlyZ2ZmcDdHSXppVE4wN2Mza25xeGRkcXdYSlRKWTM4VTllemtV?oc=5","date":"2024-09-16","type":"trial","source":"Clinical Trials Arena","summary":"The crucial role of mobile visits in a DCT for interstitial lung disease - Clinical Trials Arena","headline":"The crucial role of mobile visits in a DCT for interstitial lung disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPbEZaWjdVY2cxMU5LZXduZ00ybFE5WmRnOG1JUTlfU1VJLWhDNXd2TUZaYThXdVFXdmJPZ01FZWNBVEFZaV9HcGdYeWFoakprVWlzOTFsZVlmZXRKd2ZmaXZjYXlyX1VyR0k0OXRzOHEwN3hZLU4ybEx4dWZZS3liaUVROWVhckU5MldNRklYQUFWNkUwMWU2ckZrZlMxcS1iZGMwRU45dnlaanJSX3ZFNDd4aE92eEFkblFUTGpTaGRQdw?oc=5","date":"2023-09-06","type":"pipeline","source":"BioSpace","summary":"Heroes in the Fight: Octapharma To Be Honored for Myositis Research at TMA Annual Patient Conference - BioSpace","headline":"Heroes in the Fight: Octapharma To Be Honored for Myositis Research at TMA Annual Patient Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE9sV0N6a25tamR2eDg1dE94MjN3TGJkUnUtdFlBWnQxVzBSQzBueTVfekJvUi1JWVF0TjhhcnY1YWQybTBVUEh5QzZtZ0JQcHVOVFhzRHdMdHE0TTA?oc=5","date":"2022-10-06","type":"trial","source":"EurekAlert!","summary":"ProDERM study results of Octagam® 10% treatment in patients with dermatomyositis published in the New England Journal of Medicine - EurekAlert!","headline":"ProDERM study results of Octagam® 10% treatment in patients with dermatomyositis published in the New England Journal of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQZEhSeFoyMXJyNWlPSktLUE44d3hEMjYyN0kyM0tMQjdFX1JycGtnRnNUQ2VIc1BYZEEyWmhscVpJTmVNWVpfN2EwRURmaUNNTl9uME9JVkc3SmJLdXZlRGJqM3Z1SXVMVF9rYng5MDFQS29QOTRCM0pMRDJ6UWxnSHZBcmx1bkxHTlpYTHlPV3hoWFM0d3B3eUM4SklQZlMzQkZUQjlUa1JGQlo5ODF4d0pscHF0UW5MRUE?oc=5","date":"2021-07-20","type":"regulatory","source":"Business Wire","summary":"FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis - Business Wire","headline":"FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2016-06-04","type":"pipeline","source":"Business Standard","summary":"Reliance Industries restarts PTA plants at Dahej - Business Standard","headline":"Reliance Industries restarts PTA plants at Dahej","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}